Out of the eight analysts that have coverage on Aster DM Healthcare, seven of them have a “buy” rating on the stock, while the other one has a “hold” recommendation.
Out of the eight analysts that have coverage on Aster DM Healthcare, seven of them have a “buy” rating on the stock, while the other one has a “hold” recommendation.